8-K - Acurx Pharmaceuticals, Inc. (0001736243) (Filer)
据 SEC EDGAR 8-K 文件，Acurx Pharmaceuticals, Inc.（CIK 0001736243）于 2026-10-29 提交并获受理的 8-K 报告涉及 Item 5.03（公司章程或细则修订；财年变更）和 Item 9.01（财务报表与附件），报告期为 2026-10-29，文件共 12 份。
报错 · 内容有误？请告诉我们。
Filing Date
2026-10-29
Accepted
2026-10-29 17:20:58
Documents
12
Period of Report
2026-10-29
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits
Mailing Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305
Business Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305 917-533-1469
Acurx Pharmaceuticals, Inc. (Filer) CIK: 0001736243 (see all company filings)
EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40536 | Film No.: 261502935
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)
来源：SEC EDGAR 8-K · sec.gov